Evelo Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
EVLO Nasdaq 8731 https://evelobio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Evelo Biosciences Inc

Evelo Biosciences, Inc. (NASDAQ:EVLO) Q4 2022 Earnings Call Transcript - Mar 21st, 2023 2:46 am
Q4 2022 Evelo Biosciences Inc Earnings Call - Mar 17th, 2023 2:23 am
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights - Mar 16th, 2023 11:00 am
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 - Mar 9th, 2023 11:00 am
After Plunging -40.39% in 4 Weeks, Here's Why the Trend Might Reverse for Evelo Biosciences, Inc. (EVLO) - Mar 1st, 2023 2:35 pm
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference - Mar 1st, 2023 11:00 am
Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial - Feb 27th, 2023 11:00 am
Down -39.46% in 4 Weeks, Here's Why Evelo Biosciences, Inc. (EVLO) Looks Ripe for a Turnaround - Feb 13th, 2023 2:35 pm
Flagship-backed biotech cuts nearly half its staff - Feb 1st, 2023 6:56 pm
Evelo Biosciences' Atopic Dermatitis Study Fails, Observes Unusually High Placebo Response Rates - Feb 1st, 2023 5:53 pm
UPDATE 1-Evelo Biosciences to cut jobs, skin disease drug trial disappoints - Feb 1st, 2023 1:04 pm
Evelo Biosciences Provides Clinical and Business Updates - Feb 1st, 2023 12:30 pm
Horizon Technology Finance Provides Fourth Quarter 2022 Portfolio Update - Jan 11th, 2023 9:15 pm
Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt - Dec 16th, 2022 11:01 am
Evelo Biosciences, Inc. (NASDAQ:EVLO) insiders placed bullish bets worth US$575k in the last 12 months - Dec 1st, 2022 12:40 pm
Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology - Nov 15th, 2022 9:01 pm
Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights - Nov 14th, 2022 10:27 pm
Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference - Nov 8th, 2022 11:00 am
Evelo Biosciences Presents Biomarker Data Demonstrating Anti-inflammatory Effects of EDP1815 in Psoriasis at the 2022 European Academy of Dermatology and Venereology (EADV) Congress - Sep 7th, 2022 5:00 am
Evelo Biosciences Announces Grant of Inducement Award - Sep 1st, 2022 9:15 pm